27
Aug
2024
Maithili Life Sciences Private Limited
Exhibitor at CPHI Korea 2024 stand R11
About Us
Categories
-
IN -
2018On CPHI since
Event information
CPHI Korea 2024
-
27 - 29 August 2024
-
COEX, Seoul, Korea
-
Visit us at stand R11
Products Featured at CPHI Korea 2024
-
![4-[4-Dimethyl amino)-1-(4'-fluoro phenyl)-1-hydroxybutyl-3-(hydroxy Methyl)-benzonitrile hydro bromide [103146-26-5]](https://www.cphi-online.com/img/v2021/product_image.png)
Product 4-[4-Dimethyl amino)-1-(4'-fluoro phenyl)-1-hydroxybutyl-3-(hydroxy Methyl)-benzonitrile hydro bromide [103146-26-5]
Escitalopram Oxalate intermediate -
Product Nebivolol Hydrochloride
ODMF available. Nebivolol is used to treat hypertension (high blood pressure). Lowering blood pressure may lower your risk of a stroke or heart attack. -
Product (+)-(R*)-6-Fluoro-2-[(S*)-oxiran-2-yl)chroman (ISOMER A);CAS#793669-26-8
Isomer A of Nebivolol Hcl available -
Product Biperiden Hydrochloride
ODMF available. Biperiden is used to treat Parkinson disease and certain drug-induced movement disorders. -
Product Dapoxetine Hydrochloride
ODMF available. Dapoxetine is the first compound developed specially for the treatment of premature ejaculation in men around18–64 years old.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance